Published in Chemotherapy on February 29, 2012
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med (2012) 7.18
Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol (2009) 2.53
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer (2008) 2.08
Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol (2007) 1.92
Role of magnetic resonance cholangiopancreatography in patients with suspected choledocholithiasis. Mayo Clin Proc (2002) 1.84
5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology (2010) 1.71
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol (2007) 1.67
Risk of cancer in cases of suspected lynch syndrome without germline mutation. Gastroenterology (2013) 1.55
Oncogenicity of the developmental transcription factor Sox9. Cancer Res (2012) 1.55
Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. J Natl Cancer Inst (2013) 1.47
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy. J Clin Gastroenterol (2015) 1.45
[Carcinoid tumor of the intrahepatic biliary tract]. Cir Esp (2006) 1.39
Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology (2012) 1.38
Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol (2008) 1.37
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study). Scand J Gastroenterol (2010) 1.33
Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol (2012) 1.28
Malignant colorectal polyps. World J Gastroenterol (2010) 1.27
A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS One (2012) 1.24
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol (2009) 1.23
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am J Gastroenterol (2006) 1.22
Mouse models of pancreatic cancer. World J Gastroenterol (2012) 1.20
Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation. J Biol Chem (2013) 1.18
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies. Gastrointest Endosc (2012) 1.15
Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl (2002) 1.14
Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol (2013) 1.10
'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures. Helicobacter (2003) 1.06
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter (2004) 1.05
Littoral-cell angioma of the spleen: a case report. World J Gastroenterol (2007) 1.03
Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients. Hum Immunol (2009) 1.01
MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res (2010) 1.01
Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations. PLoS One (2013) 1.00
Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. Gastrointest Endosc (2013) 1.00
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. Drug Metab Rev (2012) 1.00
Cytomegalovirus hepatitis and myopericarditis. World J Gastroenterol (2007) 0.98
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib. Hepatology (2013) 0.98
Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol (2013) 0.97
Using a modified technology acceptance model to evaluate healthcare professionals' adoption of a new telemonitoring system. Telemed J E Health (2011) 0.97
Adjuvant and neoadjuvant treatment in pancreatic cancer. World J Gastroenterol (2012) 0.96
Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats. Nutrition (2013) 0.96
Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol (2011) 0.96
Liver iron concentration quantification by MRI: are recommended protocols accurate enough for clinical practice? Eur Radiol (2010) 0.96
Anastrozole-induced hepatotoxicity. Eur J Gastroenterol Hepatol (2006) 0.95
Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am J Gastroenterol (2008) 0.94
Fecal immunochemical test accuracy in familial risk colorectal cancer screening. Int J Cancer (2013) 0.92
Inflammatory mediators of hepatic steatosis. Mediators Inflamm (2010) 0.91
A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12. BMC Genomics (2013) 0.91
p73 plays a role in erythroid differentiation through GATA1 induction. J Biol Chem (2009) 0.91
Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. Cardiovasc Diabetol (2013) 0.91
Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. Dis Esophagus (2009) 0.90
Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci (2014) 0.89
Genetic susceptibility variants associated with colorectal cancer prognosis. Carcinogenesis (2013) 0.89
c-Met in pancreatic cancer stem cells: therapeutic implications. World J Gastroenterol (2012) 0.88
[III Spanish Consensus Conference on Helicobacter pylori infection]. Gastroenterol Hepatol (2013) 0.88
Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps. Clin Cancer Res (2014) 0.88
Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis (2012) 0.87
Colorectal cancer prognosis twenty years later. World J Gastroenterol (2010) 0.87
MicroRNAs in biliary diseases. World J Gastroenterol (2012) 0.87
Renal transplantation in the elderly. Int Urol Nephrol (2008) 0.87
Outcome of liver transplantation using donors older than 60 years of age. Clin Transplant (2010) 0.87
Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice. Ann Hepatol (2013) 0.86
Clinical subtypes and molecular characteristics of serrated polyposis syndrome. Clin Gastroenterol Hepatol (2013) 0.86
BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populations. Carcinogenesis (2012) 0.86
Self-expanding esophageal prostheses as an alternative temporary treatment for achalasia. Gastrointest Endosc (2009) 0.86
Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery. BMC Med (2014) 0.85
Impact of aberrant arterial anatomy and location of anastomosis on technical outcomes after liver transplantation. J Gastrointest Surg (2005) 0.85
Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis. Inflammation (2003) 0.85
CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate. BMC Gastroenterol (2006) 0.84
Alcohol consumption on pancreatic diseases. World J Gastroenterol (2013) 0.84
Comparison between magnetic resonance cholangiopancreatography and ERCP for evaluation of the pancreatic duct. Am J Gastroenterol (2002) 0.84
Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice. Pharmacol Res (2010) 0.83
[Pancreatic metastases due to renal carcinoma. Our cases and a literature review]. Cir Esp (2012) 0.83
Molecular markers in pancreatic cancer diagnosis. Clin Chim Acta (2013) 0.83
Prognosis and follow-up of 135 patients with ischemic colitis over a five-year period. World J Gastroenterol (2013) 0.83
Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome. BMC Med Genet (2011) 0.82
Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study. J Crohns Colitis (2010) 0.82
Biochemical determination of lipid content in hepatic steatosis by the Soxtec method. World J Gastroenterol (2010) 0.82
MicroRNAs and cholestatic liver diseases. Curr Opin Gastroenterol (2014) 0.82
Susceptibility genetic variants associated with early-onset colorectal cancer. Carcinogenesis (2012) 0.82
[Plasma levels of folate and vitamin B(12) in patients with chronic liver disease]. Gastroenterol Hepatol (2010) 0.81